These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Aprotinin use in cardiac surgery patients at low risk for requiring blood transfusion. Kristeller JL; Stahl RF; Roslund BP; Roke-Thomas M Pharmacotherapy; 2007 Jul; 27(7):988-94. PubMed ID: 17594204 [TBL] [Abstract][Full Text] [Related]
26. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial. Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838 [TBL] [Abstract][Full Text] [Related]
27. Increased incidence of acute kidney injury with aprotinin use during cardiac surgery detected with urinary NGAL. Wagener G; Gubitosa G; Wang S; Borregaard N; Kim M; Lee HT Am J Nephrol; 2008; 28(4):576-82. PubMed ID: 18264006 [TBL] [Abstract][Full Text] [Related]
28. Aprotinin in primary cardiac surgery: operative outcome of propensity score-matched study. Ngaage DL; Cale AR; Cowen ME; Griffin S; Guvendik L Ann Thorac Surg; 2008 Oct; 86(4):1195-202. PubMed ID: 18805159 [TBL] [Abstract][Full Text] [Related]
29. Effects of aprotinin dosage on renal function: an analysis of 8,548 cardiac surgical patients treated with different dosages of aprotinin. Dietrich W; Busley R; Boulesteix AL Anesthesiology; 2008 Feb; 108(2):189-98. PubMed ID: 18212563 [TBL] [Abstract][Full Text] [Related]
30. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting. Bittner HB; Lemke J; Lange M; Rastan A; Mohr FW Ann Thorac Surg; 2008 May; 85(5):1662-8. PubMed ID: 18442562 [TBL] [Abstract][Full Text] [Related]
31. Aprotinin, blood loss, and renal dysfunction in deep hypothermic circulatory arrest. Mora Mangano CT; Neville MJ; Hsu PH; Mignea I; King J; Miller DC Circulation; 2001 Sep; 104(12 Suppl 1):I276-81. PubMed ID: 11568069 [TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of aprotinin in cardiac surgery. Levy JH Orthopedics; 2004 Jun; 27(6 Suppl):s659-62. PubMed ID: 15239553 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of a high-dose aprotinin regimen for reducing transfusion requirements and inflammatory responses in adult cardiac surgery. Jeong DS; Kim KH; Kim CY; Kim JS J Int Med Res; 2008; 36(5):1039-48. PubMed ID: 18831899 [TBL] [Abstract][Full Text] [Related]
34. Aprotinin. A review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery. Davis R; Whittington R Drugs; 1995 Jun; 49(6):954-83. PubMed ID: 7543841 [TBL] [Abstract][Full Text] [Related]
35. Preoperative platelet dysfunction increases the benefit of aprotinin in cardiopulmonary bypass. Ray MJ; Marsh NA; Just SJ; Perrin EJ; O'Brien MF; Hawson GA Ann Thorac Surg; 1997 Jan; 63(1):57-63. PubMed ID: 8993241 [TBL] [Abstract][Full Text] [Related]
37. Replacement of aprotinin by ε-aminocaproic acid in infants undergoing cardiac surgery: consequences for blood loss and outcome. Martin K; Gertler R; MacGuill M; Mayr NP; Hapfelmeier A; Hörer J; Vogt M; Tassani P; Wiesner G Br J Anaesth; 2013 Apr; 110(4):615-21. PubMed ID: 23213034 [TBL] [Abstract][Full Text] [Related]